METTL3 and hepatocellular carcinoma: Mechanistically, METTL3 down-regulated the expression of E3 ligase TRIM21 via m6A modification to increase the protein stability of glucose-6-phosphate dehydrogenase (G6PD), contributing to reduced HCC sensitivity to OXA.